Could look at options of listing Suven Neurosciences, says Suven Life Sciences

Shares of Suven Life Sciences fell 93 percent on January 21 as the stock traded ex-demerger of its contract research and manufacturing services (CRAMS) business with effect from yesterday. The record date for demerger is January 22, which means one has to have Suven Life's shares in his/her account by end of this day and then he/she will be eligible for shares of CRAMS business. Venkat Jasti, chairman and CEO of Suven Life Sciences discussed this in detail.